N-(2,3-dihydroxybenzoyl)serine synthetase
RxNorm 12797
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 12797 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: N-(2,3-dihydroxybenzoyl)serine synthetase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
2,3-dihydroxybenzoate serine ligase
(Atom ID: 10794547)
FN
Full form of descriptor (FN):
2,3-dihydroxybenzoate serine ligase (substance)
(Atom ID: 10794548)
SY